Immunogenicity and Safety of Meningococcal Groups A and C and Haemophilus b Conjugate Vaccine in Infants 2 to 5 Months of Age
Immunogenicity and Safety of Adjuvant and Adjuvant-Free Meningococcal Groups A and C and Haemophilus b Conjugate Vaccine in Infants 2 to 5 Months of Age
Sponsor: Air Force Military Medical University, China
Listed as NCT02919293, this PHASE1/PHASE2 trial focuses on Meningitis and Meningococcal Infections and remains ongoing. Sponsored by Air Force Military Medical University, China, it has been updated 9 times since 2016, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE1/PHASE2
Status: Unknown Status → Unknown · Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Oct 2021 — Jul 2024 [monthly]
Unknown Status PHASE1_PHASE2
-
Jan 2021 — Oct 2021 [monthly]
Unknown Status PHASE1_PHASE2
-
Nov 2020 — Jan 2021 [monthly]
Unknown Status PHASE1_PHASE2
▶ Show 4 earlier versions
-
Apr 2019 — Nov 2020 [monthly]
Unknown Status PHASE1_PHASE2
-
Sep 2018 — Apr 2019 [monthly]
Unknown Status PHASE1_PHASE2
Status: Recruiting → Unknown Status
-
May 2017 — Sep 2018 [monthly]
Recruiting PHASE1_PHASE2
-
Jan 2017 — May 2017 [monthly]
Recruiting PHASE1_PHASE2
First recorded
Aug 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Air Force Military Medical University, China
- Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
- Guangdong Center for Disease Prevention and Control
- Guizhou Center for Disease Control and Prevention
- National Institutes for Food and Drug Control, China
- Simoon Record Pharma Information Consulting Co., Ltd.
For direct contact, visit the study record on ClinicalTrials.gov .